Testing effectiveness (Phase 2)UnknownNCT04069949
What this trial is testing
Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus
Who this might be right for
Unresectable Hepatocellular CancerPortal Vein Tumor Thrombus
Sichuan University 39